Estimated Lifetime Benefits of Combination Therapy With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Non-Steroidal MRAs in Patients With Type 2 Diabetes and Albuminuria

被引:2
作者
Neuen, Brendon L.
Perkovic, Vlado
Bakris, George L.
Heerspink, Hiddo Lambers
Vaduganathan, Muthiah
机构
关键词
Cardiometabolic health; Diabetes Mellitus; Clinical trials; Kidney Disease;
D O I
10.1161/circ.148.suppl_1.17437
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A17437
引用
收藏
页数:3
相关论文
empty
未找到相关数据